Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
ReCAP: Insights Into the Potential Preventability of Oncology Readmissions.
Journal: Journal of oncology practice
Published: January 21, 2016
A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma.
Journal: Molecular cancer therapeutics
Published: June 08, 2015
Patient Attitudes Regarding the Cost of Illness in Cancer Care.
Journal: The oncologist
Published: April 24, 2015
Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models.
Journal: Molecular cancer therapeutics
Published: February 25, 2014
Showing 1-4 of 4
Last Updated: 09/26/2026